Keean Sarani Net Worth (Estimated)

Who is Keean Sarani?

Keean Sarani is a founder associated with Avro Life Science, a company that participated in Y Combinator's W18 batch.

About Avro Life Science

Skin patches for generic drug delivery.

Model inputs

• Stage: seed
• Valuation tier: raise-10x
• Funding input: reported raise $120K
• Research as-of: 2026-08-04
• Funding source: https://www.seedtable.com/startups/Avro_Life_Science-4N9ZY63

FAQ: Keean Sarani net worth and Avro Life Science valuation

What is Keean Sarani's net worth?

Keean Sarani's estimated net worth / paper wealth is $600K (range $420K–$900K) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.

Keean Sarani net worth

Keean Sarani's estimated net worth / paper wealth is $600K (range $420K–$900K) as of 2026. This Keean Sarani net worth figure is estimated paper wealth, not a verified statement of assets.

How much is Keean Sarani worth?

Keean Sarani's estimated net worth / paper wealth is $600K (range $420K–$900K) as of 2026. How much Keean Sarani is worth here means estimated paper wealth from public company and role data — not financial advice.

How rich is Keean Sarani?

Keean Sarani's estimated net worth / paper wealth is $600K (range $420K–$900K) as of 2026. “How rich is Keean Sarani” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.

Keean Sarani fortune

Keean Sarani's estimated net worth / paper wealth is $600K (range $420K–$900K) as of 2026. This Keean Sarani fortune figure is estimated paper wealth only, not a verified statement of assets.

Keean Sarani equity value

Keean Sarani's estimated net worth / paper wealth is $600K (range $420K–$900K) as of 2026. Keean Sarani equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.

What is Avro Life Science valuation?

Avro Life Science's estimated valuation on Entrepreneurial Check is $1.2M. Independent model output, not a verified appraisal or official mark.

What is Avro Life Science post-money valuation?

Avro Life Science's estimated valuation on Entrepreneurial Check is $1.2M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.

What is Avro Life Science funding?

Avro Life Science funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Avro Life Science raised is not a complete cap table — figures are estimates only.

How much did Avro Life Science raise?

How much Avro Life Science raised, when disclosed, informs the estimated Avro Life Science valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.

How much money did Avro Life Science raise?

How much money Avro Life Science raised, when a public figure is available, is a model input for the estimated Avro Life Science valuation on this profile. Estimates only — not a complete cap table.

What is Avro Life Science series funding?

Avro Life Science series funding, when a public raise is disclosed, informs the estimated Avro Life Science valuation here. Not a complete financing history.

What company is Keean Sarani building?

Keean Sarani is Founder at Avro Life Science, a Y Combinator-backed startup (batch W18).

What does Avro Life Science do?

Avro Life Science — Skin patches for generic drug delivery.

What YC batch is Keean Sarani from?

Keean Sarani is associated with Y Combinator batch W18.

Where is Keean Sarani based?

Public directory data lists Keean Sarani's region as Canada.

What industry is Keean Sarani in?

Keean Sarani is listed under Healthcare, Drug Discovery and Delivery.

How big is Avro Life Science?

Public data lists Avro Life Science's team size as 8.

Is Entrepreneurial Check affiliated with Y Combinator?

No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.